◆ Controlled pilot

A secure first check for pharmaceutical brand names.

The current ONOMA pilot provides authenticated, server-side checking for exact and similar governed-registry names. It does not yet provide the full generation, six-gate screening, dossier or regulatory-decision workflow.

Server-verified workspace accessGoverned registry integrity prerequisite◆ Advisory pilot — not a regulatory decision
Current scope

What this controlled pilot provides

1

Verify access

Server-verified accounts and company access with no local workspace fallback.

2

Check conflicts

Limited exact and similarity checking against an integrity-verified governed registry.

3

Fail closed

No result is calculated when the account, tenant, registry version, count or digest cannot be verified.

4

Generation

Unavailable until the full ingredient-echo, INN/USAN, LASA and regulatory gates are migrated and validated.

5

Dossier & workflow

Not included in the current secure pilot; these features remain in controlled migration.

6

Decision status

Advisory screening support only. The relevant health authority makes the regulatory decision.

Pilot access

Open ONOMA

Secure controlled pilot

For approved pilot accounts. Provides the limited registry-conflict check described above.

Open secure pilot ▸

Synthetic demonstration

Explore an invented, offline example with no account, customer data or real registry.

Try synthetic demo ▸

Controlled-pilot status: limited registry-conflict screening only. No regulatory-acceptance probability or threshold is claimed. ONOMA advises; the relevant health authority decides.

The Veridiqa family

Part of a connected suite